Markets:

Overview

News

Currencies

International

Treasuries

eFFECTOR Therapeutics, Inc. - Common Stock (NQ:EFTR)

0.1800 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about eFFECTOR Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

3 Publicly Traded Companies Filing for Bankruptcy as July Kicks Off ↗

July 15, 2024

Explore bankruptcy risk stocks with insights on Chicken Soup for the Soul Entertainment, eFFECTOR Therapeutics, and Delta Apparel.

Via InvestorPlace

Topics Bankruptcy

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 26, 2024

It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!

Via InvestorPlace

Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher ↗

June 24, 2024

Via Benzinga

Topics Stocks

Why eFFECTOR Therapeutics (EFTR) Shares Are Down Over 70% ↗

June 24, 2024

EFFECTOR Therapeutics shares are trading lower by 74% during Monday's session. The company announced that it has terminated its employees and will wind down its operations.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 28, 2024

Via Benzinga

EFTR Stock Earnings: eFFECTOR Therapeutics Meets EPS for Q1 2024 ↗

May 09, 2024

EFTR stock results show that eFFECTOR Therapeutics met analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 05, 2024

Via Benzinga

Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results ↗

April 04, 2024

U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88....

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 04, 2024

Via Benzinga

Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 04, 2024

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%...

Via Benzinga

Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings ↗

April 04, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 150 points on Thursday. The Dow traded up 0.49% to 39,319.03 while the NASDAQ rose 1% to 16,4340. The S&P...

Via Benzinga

Topics Stocks

Cancer-Focused eFFECTOR Therapeutics Shelves Development Of Lung Cancer Candidate After Disappointing Data ↗

April 04, 2024

eFFECTOR Therapeutics unveils Phase 2 KICKSTART trial results for tomivosertib with Keytruda in NSCLC patients. Tomivosertib shows modest activity, but no clear path forward. Zotatifin emerges as a...

Via Benzinga

Dow Jumps Over 100 Points; US Jobless Claims Increase To 221,000 ↗

April 04, 2024

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.34% to 39,259.15 while the NASDAQ...

Via Benzinga

Topics Stocks

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 26, 2024

It's time to dive into the biggest pre-market stock movers on Tuesday as we check out all of the hottest news moving shares this morning!

Via InvestorPlace

EFTR Stock Earnings: eFFECTOR Therapeutics Misses EPS for Q4 2023 ↗

March 25, 2024

EFTR stock results show that eFFECTOR Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 08, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 25, 2024

Pre-market stock movers are a hot topic on Thursday morning and we have all the coverage traders need to know about today.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 24, 2024

Via Benzinga

Dow Tumbles Over 200 Points; US Trade Gap Narrows In November ↗

January 09, 2024

U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.63% to 37,445.51 while the NASDAQ fell...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 09, 2024

Via Benzinga

Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket ↗

January 08, 2024

Shares of LumiraDx Limited (NASDAQ: LMDX) shares fell sharply in pre-market trading. LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th....

Via Benzinga

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 11, 2023

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the...

Via Benzinga

Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket ↗

December 11, 2023

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some...

Via Benzinga

eFFECTOR Therapeutics Discloses Updated Data From Mid-Stage Breast Cancer Study ↗

December 08, 2023

eFFECTOR Therapeutics Inc (NASDAQ: EFTR) announced new interim data from dose escalation and Phase 2 expansion cohorts of a Phase 1/2 study of zotatifin in patients with estrogen receptor positive...

Via Benzinga

Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 13, 2023

Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.

Via Benzinga

Why StoneCo Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket ↗

November 13, 2023

StoneCo Ltd. (NASDAQ: STNE) shares rose in pre-market trading after the company reported upbeat results for its third quarter on Friday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 13, 2023

Pre-market stock movers are worth checking out on Monday as we cover all of the biggest gainers and losers this morning!

Via InvestorPlace

3 Promising Biotech Stocks That Will Make Early Investors Rich ↗

October 02, 2023

Despite their volatility, certain biotech stocks stand out for their innovative approaches and potential game-changing therapies.

Via InvestorPlace

eFFECTOR Stock To Rally Over 500%? Analyst Predict Blockbuster Status For Cancer Candidates ↗

August 24, 2023

HC Wainwright has initiated coverage on eFFECTOR Therapeutics Inc (NASDAQ: EFTR) with a Buy rating

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

eFFECTOR Therapeutics, Inc. - Common Stock (NQ:EFTR)

Headline News about eFFECTOR Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today